Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02125084 |
| Title | Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer |
| Recruitment | Completed |
| Gender | male |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | SCRI Development Innovations, LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Florida Cancer Specialists | Fort Myers | Florida | 33916 | United States | Details | |
| Florida Cancer Center | Saint Petersburg | Florida | 33705 | United States | Details | |
| Oncology Hematology Care Inc. | Cincinnati | Ohio | 45242 | United States | Details | |
| Tennessee Oncology | Chattanooga | Tennessee | 37404 | United States | Details | |
| Tennessee Oncology PLLC | Nashville | Tennessee | 37203 | United States | Details |